Latest stories on REPL
Bronstein, Gewirtz & Grossman LLC Urges Replimune Group, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire34 · bearishgeneral
REPL Investor Alert: Replimune Group, Inc. Securities Class Action Notice - Contact SueWallSt
PR Newswire34 · bearishgeneral
Bronstein, Gewirtz & Grossman LLC Urges Replimune Group, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Business Insider34 · bearishgeneral
REPL UPCOMING DEADLINE: SueWallSt Alerts Replimune Group, Inc. Stockholders of Securities Class Action - Contact the Firm
GlobeNewswire48 · neutralgeneral
REPL Investors Have Opportunity to Lead Replimune Group, Inc. Securities Fraud Lawsuit with SBS Law
Barchart34 · bearishgeneral
Bronstein, Gewirtz & Grossman LLC Urges Replimune Group, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire34 · bearishgeneral
REPL DEADLINE: SueWallSt Reminds Replimune Group, Inc. Investors of Upcoming Securities Class Action Deadline
PR Newswire34 · bearishgeneral
Replimune to Present at the Cantor Global Healthcare Conference 2026
StockTitan55 · neutralgeneral
Bronstein, Gewirtz & Grossman LLC Urges Replimune Group, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire34 · bearishgeneral
Bronstein, Gewirtz & Grossman LLC Urges Replimune Group, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire34 · bearishgeneral
Replimune Group, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - REPL
PR Newswire34 · bearishgeneral
Why Did SJM, REPL, NEO Stocks Surge To 52-Week Highs Today?
Stocktwits News67 · bullishearnings
Replimune price target raised to $21 from $20 at JPMorgan
The Fly61 · neutralanalyst
Bronstein, Gewirtz & Grossman LLC Urges Replimune Group, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire34 · bearishgeneral
Bronstein, Gewirtz & Grossman LLC Urges Replimune Group, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire34 · bearishgeneral
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire50 · neutralgeneral